About this funding solution
A pre-IPO investment is late-stage capital raised roughly six months to two years before a listing, aimed at strengthening the balance sheet, funding expansion and tightening corporate governance ahead of public-market scrutiny.
These rounds are typically structured as private placements, secondary share sales, or instruments like compulsorily/optionally convertible debentures and preference shares — often carrying warrants that let the investor convert to equity on defined milestones.
Investors at this stage are usually private equity funds, family offices and high-net-worth individuals seeking exposure to a company nearing a liquidity event, rather than early-stage venture funds.
Pre-IPO rounds are privately negotiated; pricing and structure vary by company stage, sector and investor appetite.
Who is this solution for?
For companies with a credible listing timeline that need capital or governance runway to get there.
- Targeting an IPO within the next 6–24 months
- Need capital to strengthen the balance sheet ahead of listing
- Corporate governance or board structure needs tightening before scrutiny
- Want investor introductions to PE funds, family offices or HNIs specifically
Why consider this funding route?
Listing-stage investor access
Introductions to PE funds, family offices and HNIs focused on pre-IPO stage.
Instrument structuring
CCDs, OCDs and preference shares structured to fit your cap table and timeline.
Governance readiness
Support tightening board composition and compliance ahead of public scrutiny.
Valuation continuity
Round pricing benchmarked to support, not undercut, your eventual IPO pricing.
How it works
Listing-readiness assessment
Governance, financials and timeline reviewed against IPO-readiness benchmarks.
Instrument structuring
Appropriate instrument (CCD/OCD/preference shares) proposed for the raise.
Investor outreach
Curated introductions to PE, family office and HNI investors.
Negotiation & close
Support through term sheet negotiation, due diligence and closing.
Dilution & Valuation Estimator
Use the sliders below to get an indicative estimate. Final terms are subject to formal underwriting and lender / investor committee assessment.
FAQs
It's specifically timed and structured around an upcoming listing — instruments and investor base are chosen to support IPO governance and valuation continuity, not just growth capital.
Compulsorily or optionally convertible debentures and preference shares are common, often with conversion triggers tied to listing milestones.
Private equity funds, family offices and high-net-worth individuals seeking exposure to a near-term liquidity event.
Not if structured correctly — we benchmark round pricing and instrument terms to support rather than conflict with your IPO valuation and cap table.
Check Eligibility
Submit details. Our desk reviews profile variables and calls you back the same working day.